Abstract
We report the synthesis of 3-phenethylazetidine derivatives 2 and their biological activities against 5-HT, NE and DA transporters as well as microsomal stability, CYP inhibition, and hERG inhibition profiles. Compound 2at showed most potent triple reuptake inhibitor with good selectivity as a candidate for depression.
Keywords:
3-Phenethylazetidines; Antidepressant; Depression; Triple reuptake inhibitor.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Azetidines / chemical synthesis
-
Azetidines / chemistry
-
Azetidines / pharmacology*
-
Biological Transport / drug effects
-
Cytochrome P-450 Enzyme Inhibitors / chemical synthesis
-
Cytochrome P-450 Enzyme Inhibitors / chemistry
-
Cytochrome P-450 Enzyme Inhibitors / pharmacology*
-
Cytochrome P-450 Enzyme System / metabolism*
-
Ether-A-Go-Go Potassium Channels / antagonists & inhibitors*
-
Ether-A-Go-Go Potassium Channels / metabolism
-
Humans
-
Molecular Structure
-
Neurotransmitter Uptake Inhibitors / chemical synthesis
-
Neurotransmitter Uptake Inhibitors / chemistry
-
Neurotransmitter Uptake Inhibitors / pharmacology*
-
Phenyl Ethers / chemical synthesis
-
Phenyl Ethers / chemistry
-
Phenyl Ethers / pharmacology*
-
Plasma Membrane Neurotransmitter Transport Proteins / antagonists & inhibitors*
-
Plasma Membrane Neurotransmitter Transport Proteins / metabolism
-
Serotonin / metabolism*
-
Structure-Activity Relationship
Substances
-
3-(2-(4-chloro-3-fluorophenyl)-2-(3-fluorophenoxy)ethyl)azetidine
-
Azetidines
-
Cytochrome P-450 Enzyme Inhibitors
-
Ether-A-Go-Go Potassium Channels
-
Neurotransmitter Uptake Inhibitors
-
Phenyl Ethers
-
Plasma Membrane Neurotransmitter Transport Proteins
-
Serotonin
-
Cytochrome P-450 Enzyme System